Auto Amazon Links: No products found.
A recent analysis published in the Lancet highlights the significant impact of the human papillomavirus (HPV) vaccine introduced in England in 2008. According to the study, approximately 200 lives have been saved to date by the vaccine, which offers protection against cervical cancer. This research marks the first comprehensive assessment showing a sharp decline in deaths following the vaccination of school-age girls against HPV.
A striking milestone has been reached between 2020 and 2024, with zero reported cervical cancer deaths among women aged 20 to 24—a first in any five-year span. Experts estimate that without the vaccination program, around 23 fatalities would have been expected in this group. Professor Peter Sasieni, lead researcher from Queen Mary University of London, remarked, “It’s incredible to think that a single jab can almost eliminate a particular type of cancer.” The study also found that girls vaccinated at ages 12 or 13 now face nearly no risk of dying from cervical cancer before they turn 30. Prior to the HPV immunization campaign, there were about 20 annual deaths in this younger demographic.
Although cervical cancer remains the 14th most common cancer among females in the UK, with roughly 3,300 new cases yearly, the virus responsible for 99% of these cancers is HPV. This virus is transmitted mainly through skin-to-skin contact and often clears up without health issues. However, persistent infections can cause cellular changes that may lead to cancer many years later. The researchers expect that as more people receive the HPV vaccine and vaccinated populations age, cervical cancer mortality rates will continue to decline. Cancer Research UK, which funded the study, hailed the findings as an “incredible milestone” but expressed concern over vaccination rates in England, which fall short of recommended levels.
Sharing a personal perspective, Alexandra Legg, who missed out on the vaccine as she left school just before its introduction, was diagnosed with cervical cancer at age 30. She recalls the shock of hearing her diagnosis and the difficulties of treatment, which involved lymph node removal but left open the possibility of pregnancy. A year later, she gave birth to her daughter Ivy, whom she considers her “miracle.” Alexandra emphasizes the importance of vaccination, stating, “I’m a real advocate for this vaccine and when Ivy is old enough, she’ll be first in the queue.”
Professor Sasieni described the current reduction in deaths as just the “tip of the iceberg,” anticipating even greater life-saving effects as vaccinated cohorts age. Despite these promising developments, vaccination rates in England have dropped below critical thresholds. Data from the UK Health Security Agency revealed that 76% of girls were vaccinated by age 15 in 2024-25, under the 90% target recommended by the World Health Organization to effectively eliminate cervical cancer. Michelle Mitchell, chief executive of Cancer Research UK, urged urgent action to improve uptake, particularly in communities with low vaccination rates. While girls have been offered the vaccine for many years, boys have also been vaccinated since 2019 to help reduce HPV transmission and protect against several types of cancer. The Department of Health and Social Care emphasized the “extraordinary impact” of the vaccine and outlined ongoing efforts, including catch-up campaigns in pharmacies and the distribution of self-testing kits to encourage cervical screening among women who have yet to attend
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.